Paragon Capital Management (Colorado)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-532
Closed -$261K 178
2022
Q1
$261K Buy
532
+17
+3% +$7.77K 0.05% 111
2021
Q4
$239K Buy
+515
New +$217K 0.04% 127
2018
Q1
Sell
-1,550
Closed -$349K 224
2017
Q4
$349K Hold
1,550
0.14% 69
2017
Q3
$294K Buy
+1,550
New +$295K 0.11% 108
2017
Q2
Sell
-1,391
Closed -$230K 186
2017
Q1
$230K Buy
+1,391
New +$221K 0.1% 104

Other funds holding ELV

Paragon Capital Management (Colorado)'s ELV Position: Q2 2022 in Review

Paragon Capital Management (Colorado) sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 532 shares — an estimated $261K sold.

Paragon Capital Management (Colorado) first reported a position in ELV in Q1 2017 and held it in 5 quarters. The position peaked at $349K in Q4 2017. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Paragon Capital Management (Colorado) reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • Paragon Capital Management (Colorado) sold 532 Elevance Health shares in Q2 2022, an estimated $261K.
  • Paragon Capital Management (Colorado) first reported a position in Elevance Health in Q1 2017 and held it in 5 quarters.
  • Paragon Capital Management (Colorado)'s Elevance Health position peaked at $349K in Q4 2017.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q2 2022, filed 18 Jul 2022.